Orthotics & Prosthetics Business

Strengthening the O&P Care Chain: Ensuring High-Value Patient Outcomes

By Shane Wurderman - Chief Clinical Officer at Hanger

In orthotic and prosthetic care, we often think about our work in terms of individual roles: clinicians doing clinical work, manufacturers building components, suppliers and distributors selling components to clinics. But in reality, we are all part of a single ecosystem, which is ultimately set up to support and facilitate a care delivery chain.

Every link in the O&P care delivery chain influences whether patients ultimately receive high-value care—care that delivers the best possible outcome for an appropriate and sustainable cost. To achieve higher-quality, higher-value care, every link must apply its own filters at each linkage, determining what advances through and what does not.

Article content
 

Manufacturers: Where the Chain Begins

Even before manufacturing, the chain technically begins with raw materials. What materials are selected? How consistent are they? How do they perform under stress? Manufacturers become the first major gatekeepers, applying a filter based on:

  • Quality of raw materials
  • Testing and validation of components
  • Standards for safety and durability

Their responsibility is not simply to produce a device, but to ensure that what they pass along is capable of contributing to the best possible clinical outcome. That requires evidence, not assumptions. Measurement, not anecdotes.

This becomes the first demonstration of a principle that repeats throughout the chain: High-value care requires quantified quality at each step, going beyond just a belief that something is “good.”

Article content

 

Suppliers/Distributors: The Stewardship Filter

Suppliers and distributors serve as the connection between manufacturers and clinicians, ensuring that both quality and value are preserved as products move through the chain.

They strengthen the chain by:

  • Maintaining product integrity through proper handling, storage, and tracking
  • Verifying that items received from manufacturers meet specifications and standards
  • Communicating timely updates on product changes, recalls, or performance information
  • Supporting efficient logistics that reduce hidden costs and delays
  • Provide quick access to more choices to remove acquisition burden to provision of high-value care
  • Keeping costs reasonable so clinicians can choose based on value, not just price

By safeguarding quality and preserving value before products reach the clinic, suppliers and distributors help ensure clinicians receive reliable components at sustainable costs reinforcing the chain at a critical point.

Article content

 

Clinicians: Applying the Filter Between Device and Patient

Clinicians receive what manufacturers produce from suppliers/distributors and apply the next filter. Their responsibility is two-fold:

  1. Filter in only those technologies that demonstrate meaningful value
  2. Filter out options that may be lower cost but ultimately lower value

Clinicians determine which patients benefit from which pathways, based on:

  • Clinical outcomes
  • Patient-specific goals, priorities, and preferences
  • Functional needs
  • Evidence-informed practice
  • Patient-reported measures

This filter is crucial. A device with excellent engineering does not automatically produce an excellent outcome; the clinical application must match the patient.

But clinicians cannot do this alone, and shouldn’t be the only ones held responsible for quality.

Article content

 

Patients: The Empowerment Filter

Patients represent the final link in the care delivery chain, where all upstream decisions ultimately converge. Their engagement and expectations directly influence the value of the care delivered.

They strengthen the chain by:

  • Participating in shared-decision making to align interventions with their goals
  • Communicating personal preferences, lifestyle needs, and expectations
  • Engaging with outcome measures and follow-up assessments
  • Asking informed questions and advocating for the highest-quality options
  • Holding the system accountable by seeking providers who deliver demonstrable value

When patients are active participants rather than passive recipients, care becomes more personalized, more effective, and more likely to achieve meaningful outcomes—allowing the entire chain to deliver higher-value care.

Article content

 

But the Ecosystem Is Larger Than That

There are five other key groups that need to be recognized as critical pieces of the O&P ecosystem. These other groups are critical to strengthening the care delivery chain:

  • Clinic Owners
  • Researchers
  • Educators
  • Professional Associations
  • Payers

Each plays a distinct role in shaping whether high-value care is possible, sustainable, and measurable across the profession.

Article content

 

Clinic Owners: Creating Structure and Process

Clinic owners create the environment in which clinicians either can or cannot deliver measurable, high-value care.

They strengthen the chain by:

  • Ensuring clinicians have time and systems to collect outcome measures
  • Avoiding policies that force selection based solely on lowest price instead of best value
  • Investing in training around patient-reported outcomes and evidence use
  • Building workflows that promote timeliness, safety, and efficiency
  • Supporting cultures that reward quality, not volume

Without the owner’s filter, clinicians may want to practice value-based care but find themselves unable to because systems don’t support it.

Owners create the structure that makes quality operational.

Researchers: The Discoverers

Researchers reinforce the chain by discovering what truly works at scale and not just at individual patient.

Their role in strengthening the chain includes:

  • Designing studies that compare methods, approaches, and devices
  • Generating evidence on what provides the best outcomes
  • Identifying where variability exists and how to reduce it
  • Creating measures and indicators that clinicians can use meaningfully
  • Translating group-level findings into insights clinicians apply at the individual level

Without research, clinicians and manufacturers rely on anecdotes rather than outcomes. Measurement becomes optional instead of essential.

Research provides the clarity that the entire chain depends on.

Educators: The Knowledge Builder

Educators shape future clinicians and determine what knowledge and competencies they bring into the ecosystem.

They strengthen the chain by:

  • Teaching evidence-based pathways for O&P care
  • Helping students understand multiple care approaches and how to select among them
  • Preparing clinicians to interpret data, use outcomes, and think in terms of value
  • Embedding quality, measurement, and clinical reasoning into all aspects of training

Graduates enter the profession already capable of applying rigorous filters, rather than learning them years later by necessity.

Professional Associations: The Amplifying Voice

Associations play a unique role because they connect all other groups.

They strengthen the chain by:

  • Creating common data elements and shared language for measurement
  • Establishing expectations for professionalism and standards
  • Promoting community-wide understanding of what higher-quality, higher-value care actually means
  • Advocating to payers and policymakers about the value O&P provides
  • Helping articulate the collective strength of the chain to external stakeholders

Associations become the ecosystem’s communication hub making the chain visible and cohesive to those outside it.

Payers: The 3rd Party Arbiter

Payer’s ultimately hold the unique position within the ecosystem by serving as an external party without emotional cost. Although this sometimes creates challenging interactions, their role is critical in enforcing higher-quality, higher-value care to grow and evolve the ecosystem. Their influence radiates through every link in the chain. They want to know:

  • Which products consistently lead to better outcomes?
  • Which clinicians deliver the highest-value care?
  • Which interventions justify their cost based on measurable benefit?

This demand forces the entire ecosystem to confront a difficult truth:

O&P cannot rely indefinitely on anecdotal evidence or experience-based judgment.

As value-based care expands, every decision must be backed by quantifiable proof.

When Every Link Applies Its Filter, When Every Key Group in the Ecosystem Excels, High-Value Care Becomes the Natural Result

A care delivery chain only works when every link functions intentionally with proper support from the ecosystem. And the consistent theme across all links is this:

We must move from anecdotal assumptions to standardized, measurable results.

Do this, and most importantly: Patients receive higher-quality, higher-value care reliably and consistently.

But What About Other Groups?

Several additional groups interact with the O&P ecosystem, though their roles differ from the key entities that directly strengthen the care delivery chain. These include:

  • Regulators/Policymakers
  • Referral Sources (Physicians, PTs, Surgeons)
  • Technologists / Data & Software Infrastructure Developers
  • Technicians/Fabrication Specialists

Regulators and policymakers shape how O&P fits within the broader healthcare system, but they do not function to grow or nurture the ecosystem itself. Referral sources engage the O&P care delivery chain when directing patients for services. Their own ecosystems overlap with O&P, but they remain distinct—sometimes aligned, sometimes not. Technologists and digital infrastructure developers support the ecosystem by enabling data and insights, yet many operate across multiple industries. When their tools enter the O&P chain, it remains the responsibility of manufacturers to ensure these solutions contribute meaningfully to clinical quality and outcomes. Technicians and fabrication specialists, whether embedded within manufacturers or clinics, or operating independently, play a hands-on role in device creation. Their accountability mirrors that of manufacturers: whatever they produce must reliably support high-value care.

The Question We Must Ask Ourselves

“Where is the best starting point?”

Article content

 

The truth is, every link has its own starting point. The inability to identify a single starting point across the care delivery chain cannot continue to be the barrier to progress. We must be comfortable addressing each linkage while the others continue to operate as is until the entire chain has been strengthened one link at a time. In doing this, we will see as every individual linkage is strengthened, so too the ecosystem will grow and thrive. Higher-quality, higher-value care is not achieved by one key group doing a better job. It’s achieved when the entire ecosystem functions as a coordinated, evidence-driven system that bolsters the O&P care delivery chain.

And that chain is only as strong as the filters we apply at each linkage.

The Editor

KUET and NCKU Collaborate on Medical Technology Innovation

Next article